A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells.
Lavasani S, Dzhambazov B, Nouri M, Fåk F, Buske S, Molin G, Thorlacius H, Alenfall J, Jeppsson B, Weström B. · 2010
Read A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. by Lavasani S, Dzhambazov B, Nouri M, Fåk F, Buske S, Molin G, Thorlacius H, Alenfall J, Jeppsson B, Weström B. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2814855.txt.
Description
Lavasani and colleagues tested friendly gut bacteria in 2010 as a treatment for a mouse disease that mimics multiple sclerosis. The disease, called EAE, is an immune attack on nerve insulation. The team screened five Lactobacillus strains given daily to mice, looking for ones that calmed the attack.
Three strains cut inflammation in the brain and spinal cord and raised calming regulatory T cells. Given alone to already sick mice, each strain failed, but a mixture of all three halted the disease and reversed its signs. The benefit ran through a calming signal called IL-10, made by those regulatory cells, and transferring the cells to other mice carried the protection with them.
Catalog record
| CREATOR | Lavasani S, Dzhambazov B, Nouri M, Fåk F, Buske S, Molin G, Thorlacius H, Alenfall J, Jeppsson B, Weström B. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |